HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 48186,
"recordsTotal": 48186,
"next": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-status&start=43200",
"previous": "http://fdaaa.trialstracker.net/api/trials/?format=api&length=300&ordering=-status&start=42600",
"results": [
{
"registry_id": "NCT05284643",
"publication_url": "https://clinicaltrials.gov/study/NCT05284643",
"title": "Pilot Trial of Spectroscopic MRI-guided, Dose-Escalated Proton Radiation Therapy and Bevacizumab for Recurrent Glioblastoma",
"has_exemption": false,
"start_date": "2022-09-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Miami",
"sponsor_slug": "university-of-miami",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05345171",
"publication_url": "https://clinicaltrials.gov/study/NCT05345171",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Adeno-associated Virus (AAV) Serotype 8 (AAV8)-Mediated Gene Transfer of Human Ornithine Transcarbamylase (OTC) in Patients With Late-onset OTC Deficiency",
"has_exemption": false,
"start_date": "2022-10-18",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ultragenyx Pharmaceutical Inc",
"sponsor_slug": "ultragenyx-pharmaceutical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05367960",
"publication_url": "https://clinicaltrials.gov/study/NCT05367960",
"title": "An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome",
"has_exemption": false,
"start_date": "2022-11-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Tetra Discovery Partners",
"sponsor_slug": "tetra-discovery-partners",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05608044",
"publication_url": "https://clinicaltrials.gov/study/NCT05608044",
"title": "A Randomized, Open-Label, Phase 2 Study of Botensilimab (AGEN1181) as Monotherapy and in Combination With Balstilimab (AGEN2034) or Investigator's Choice Standard of Care (Regorafenib or Trifluridine and Tipiracil) for the Treatment of Refractory Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2022-11-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Agenus Inc.",
"sponsor_slug": "agenus-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05736549",
"publication_url": "https://clinicaltrials.gov/study/NCT05736549",
"title": "Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2",
"has_exemption": false,
"start_date": "2023-02-07",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05723198",
"publication_url": "https://clinicaltrials.gov/study/NCT05723198",
"title": "A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of Baricitinib in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata",
"has_exemption": false,
"start_date": "2023-02-27",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05703854",
"publication_url": "https://clinicaltrials.gov/study/NCT05703854",
"title": "Phase I/II Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma",
"has_exemption": false,
"start_date": "2023-03-29",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05676944",
"publication_url": "https://clinicaltrials.gov/study/NCT05676944",
"title": "Vestibular Implantation in Older Adults",
"has_exemption": false,
"start_date": "2023-04-11",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05336188",
"publication_url": "https://clinicaltrials.gov/study/NCT05336188",
"title": "Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder",
"has_exemption": false,
"start_date": "2023-05-16",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arkansas",
"sponsor_slug": "university-of-arkansas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05799144",
"publication_url": "https://clinicaltrials.gov/study/NCT05799144",
"title": "An Open-Label Phase II Clinical Trial Assessing the Safety, Feasibility, Efficacy and Immunological Correlates of Heterologous Prime-Boost With pBI-11 (IM) and TA-HPV (IM) Combined With Pembrolizumab as Treatment for Patients With Advanced, PD-L1 CPS≥1, hrHPV+ Oropharyngeal Cancer",
"has_exemption": false,
"start_date": "2023-05-16",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Michael K. Gibson",
"sponsor_slug": "michael-k-gibson",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05683171",
"publication_url": "https://clinicaltrials.gov/study/NCT05683171",
"title": "A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma",
"has_exemption": false,
"start_date": "2023-05-19",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05764733",
"publication_url": "https://clinicaltrials.gov/study/NCT05764733",
"title": "The Bone, Exercise, Alendronate, and Caloric Restriction Trial",
"has_exemption": false,
"start_date": "2023-06-08",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05937308",
"publication_url": "https://clinicaltrials.gov/study/NCT05937308",
"title": "Interventional Registry to Collect Real-World Evidence of the NEUROMARK System in Subjects With Chronic Rhinitis",
"has_exemption": false,
"start_date": "2023-06-12",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Neurent Medical",
"sponsor_slug": "neurent-medical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05335941",
"publication_url": "https://clinicaltrials.gov/study/NCT05335941",
"title": "A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma",
"has_exemption": false,
"start_date": "2023-06-13",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05909358",
"publication_url": "https://clinicaltrials.gov/study/NCT05909358",
"title": "A Phase I/II Randomized Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Sudan Ebolavirus Vaccines in Uganda",
"has_exemption": false,
"start_date": "2023-07-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Makerere University",
"sponsor_slug": "makerere-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04419272",
"publication_url": "https://clinicaltrials.gov/study/NCT04419272",
"title": "Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits: a Randomized, Double-blind, Placebo-controlled Trial",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06059690",
"publication_url": "https://clinicaltrials.gov/study/NCT06059690",
"title": "Biologic Association Between Metabolic MR-PET and Tissue Measures of Glycolysis in Brain Tumors Visualization, Quantitation, and Targeting of Infiltrating Glioblastoma Cells With pH Sensitive Amine Chemical Exchange Saturation Transfer Magnetic Resonance Imaging-KL2TR001882",
"has_exemption": false,
"start_date": "2023-09-06",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06042517",
"publication_url": "https://clinicaltrials.gov/study/NCT06042517",
"title": "Mechanisms of Ultrasound Neuromodulation Effects in Diabetes",
"has_exemption": false,
"start_date": "2023-09-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05949021",
"publication_url": "https://clinicaltrials.gov/study/NCT05949021",
"title": "OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple Negative Breast Cancer",
"has_exemption": false,
"start_date": "2023-10-07",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mridula George, MD",
"sponsor_slug": "mridula-george-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05583721",
"publication_url": "https://clinicaltrials.gov/study/NCT05583721",
"title": "An Evaluation of the Relationship Between Abnormal Myocardial Perfusion and Diastolic Dysfunction in Sickle Cell Disease Using PET (Stress-Rest) Myocardial Perfusion Imaging (MYPERS)",
"has_exemption": false,
"start_date": "2023-10-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06042153",
"publication_url": "https://clinicaltrials.gov/study/NCT06042153",
"title": "Semaglutide for Dialysis-Treated Patients - a Glucose Time in Range Study- DIALYSIS-TIR Study",
"has_exemption": false,
"start_date": "2023-12-05",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas Southwestern Medical Center",
"sponsor_slug": "university-of-texas-southwestern-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06083844",
"publication_url": "https://clinicaltrials.gov/study/NCT06083844",
"title": "Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy",
"has_exemption": false,
"start_date": "2023-12-12",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05828823",
"publication_url": "https://clinicaltrials.gov/study/NCT05828823",
"title": "Comparative Effectiveness of an Individualized Model of Hemodialysis Versus Conventional Hemodialysis",
"has_exemption": false,
"start_date": "2024-02-26",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06257875",
"publication_url": "https://clinicaltrials.gov/study/NCT06257875",
"title": "A Multicenter, Randomized Study to Evaluate the Safety and Efficacy of Lutikizumab for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2024-03-23",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05612594",
"publication_url": "https://clinicaltrials.gov/study/NCT05612594",
"title": "Adipose Dysfunction, Imaging, Physiology, and Outcomes With SGLT2i's for Sleep Apnea: The ADIPOSA Study",
"has_exemption": false,
"start_date": "2024-03-27",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06345339",
"publication_url": "https://clinicaltrials.gov/study/NCT06345339",
"title": "A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism",
"has_exemption": false,
"start_date": "2024-04-26",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06282965",
"publication_url": "https://clinicaltrials.gov/study/NCT06282965",
"title": "A Randomized, Double-blind, Placebo Controlled Study of the Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury (TBI)",
"has_exemption": false,
"start_date": "2024-05-28",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06318897",
"publication_url": "https://clinicaltrials.gov/study/NCT06318897",
"title": "Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer",
"has_exemption": false,
"start_date": "2024-05-29",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06056297",
"publication_url": "https://clinicaltrials.gov/study/NCT06056297",
"title": "A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections",
"has_exemption": false,
"start_date": "2024-06-06",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "X4 Pharmaceuticals",
"sponsor_slug": "x4-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06423300",
"publication_url": "https://clinicaltrials.gov/study/NCT06423300",
"title": "Evaluation of the Patellar LIFT System for Subjects With Patellofemoral Cartilage Degeneration",
"has_exemption": false,
"start_date": "2024-06-19",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ZKR Orthopedics Inc",
"sponsor_slug": "zkr-orthopedics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06540833",
"publication_url": "https://clinicaltrials.gov/study/NCT06540833",
"title": "A Multicenter, Randomized, Double-blind, Placebo-controlled, Flexible-dose Study to Assess the Efficacy, Safety, and Tolerability of ITI-1284 in Patients With Psychosis Associated With Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-08-15",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Intra-Cellular Therapies, Inc.",
"sponsor_slug": "intra-cellular-therapies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06193889",
"publication_url": "https://clinicaltrials.gov/study/NCT06193889",
"title": "KYSA-6: A Phase 2/3, Open-Label, Randomized, Controlled, Multicenter Study of KYV-101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor T-cell (CD19 CAR T) Therapy, Versus Ongoing Standard-Of-Care Immunosuppressive Therapy in Patients With Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kyverna Therapeutics",
"sponsor_slug": "kyverna-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220980",
"publication_url": "https://clinicaltrials.gov/study/NCT07220980",
"title": "Optimal Duration of Indwelling Urethral Foley Catheter Following Bulbar Urethroplasty: A Pragmatic Multi-Institutional Randomized Controlled Non-Inferiority Trial",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Jane Kurtzman",
"sponsor_slug": "jane-kurtzman",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06503731",
"publication_url": "https://clinicaltrials.gov/study/NCT06503731",
"title": "A Global, Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC Administered by a Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection",
"has_exemption": false,
"start_date": "2024-08-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06640998",
"publication_url": "https://clinicaltrials.gov/study/NCT06640998",
"title": "Clinical Study to Evaluate the Safety and Efficacy of Matrix Pro Applicator Treatment to Lift the Eyebrow and Lift Lax Tissue in the Submentum and Neck",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Candela Corporation",
"sponsor_slug": "candela-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06525298",
"publication_url": "https://clinicaltrials.gov/study/NCT06525298",
"title": "A Phase 1/2, Open Label Trial to Investigate the Safety, Tolerability, and Preliminary Efficacy of EIS-12656 as Single Agent and in Combination With a Poly-ADP Ribose Polymerase (PARP) Inhibitor or Trastuzumab Deruxtecan (T-DXd), an Antibody Drug Conjugate (ADC), in Participants With Specified Solid Tumors",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eisbach Bio GmbH",
"sponsor_slug": "eisbach-bio-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06594991",
"publication_url": "https://clinicaltrials.gov/study/NCT06594991",
"title": "A Phase 2 Study of Fianlimab, Cemiplimab, and Ipilimumab in Anti-PD-1 Refractory Melanoma",
"has_exemption": false,
"start_date": "2024-09-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06620705",
"publication_url": "https://clinicaltrials.gov/study/NCT06620705",
"title": "Pacing Away from Heart Failure: Left Bundle Branch Area Pacing or Biventricular Pacing in Patients with Atrial Fibrillation and Left Ventricular Dysfunction",
"has_exemption": false,
"start_date": "2024-09-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "srdpiers",
"sponsor_slug": "srdpiers",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06976671",
"publication_url": "https://clinicaltrials.gov/study/NCT06976671",
"title": "A Phase II Proof-of-concept Study Evaluating the Safety and Efficacy of Bevacizumab in the Treatment of Adhesive Capsulitis",
"has_exemption": false,
"start_date": "2024-09-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Macquarie University, Australia",
"sponsor_slug": "macquarie-university-australia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06642051",
"publication_url": "https://clinicaltrials.gov/study/NCT06642051",
"title": "Safety of the Sonablate System for the High-Intensity Focused Ultrasound (HIFU) Ablation of Incompetent Veins of the Periphery",
"has_exemption": false,
"start_date": "2024-09-11",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sonablate",
"sponsor_slug": "sonablate",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06497556",
"publication_url": "https://clinicaltrials.gov/study/NCT06497556",
"title": "A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Patients With Previously Treated KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2024-09-23",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06430385",
"publication_url": "https://clinicaltrials.gov/study/NCT06430385",
"title": "A Phase 1-2, Double-Blind, Sham-Controlled Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Patients With MECP2 Duplication Syndrome",
"has_exemption": false,
"start_date": "2024-10-21",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ionis Pharmaceuticals, Inc.",
"sponsor_slug": "ionis-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06518837",
"publication_url": "https://clinicaltrials.gov/study/NCT06518837",
"title": "FITWISE: Feasibility Study of Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer",
"has_exemption": false,
"start_date": "2024-10-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rutgers, The State University of New Jersey",
"sponsor_slug": "rutgers-the-state-university-of-new-jersey",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06589440",
"publication_url": "https://clinicaltrials.gov/study/NCT06589440",
"title": "Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)",
"has_exemption": false,
"start_date": "2024-11-20",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stingray Therapeutics",
"sponsor_slug": "stingray-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06460506",
"publication_url": "https://clinicaltrials.gov/study/NCT06460506",
"title": "A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects 12 Months of Age and Older",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06684509",
"publication_url": "https://clinicaltrials.gov/study/NCT06684509",
"title": "Using of Atorvastatin for Anthracyclin _ Associated Cardiotoxicity in Hemetological Malignancies Patients.",
"has_exemption": false,
"start_date": "2024-11-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Assiut University",
"sponsor_slug": "assiut-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06384222",
"publication_url": "https://clinicaltrials.gov/study/NCT06384222",
"title": "Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) as a Response Monitoring Tool in Patients With High-Risk Prostate Cancer Receiving Neoadjuvant Therapy",
"has_exemption": false,
"start_date": "2024-12-09",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ivan de Kouchkovsky, MD",
"sponsor_slug": "ivan-de-kouchkovsky-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06501872",
"publication_url": "https://clinicaltrials.gov/study/NCT06501872",
"title": "Safety and Effectiveness of Physician-Modified Fenestrated and Branched Aortic Endografting for the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms",
"has_exemption": false,
"start_date": "2024-12-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bjoern D. Suckow",
"sponsor_slug": "bjoern-d-suckow",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06736574",
"publication_url": "https://clinicaltrials.gov/study/NCT06736574",
"title": "A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial to Assess Efficacy and Safety of Omecamtiv Mecarbil in Patients With Symptomatic Heart Failure With Severely Reduced Ejection Fraction (COMET-HF)",
"has_exemption": false,
"start_date": "2024-12-19",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cytokinetics",
"sponsor_slug": "cytokinetics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679985",
"publication_url": "https://clinicaltrials.gov/study/NCT06679985",
"title": "A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2024-12-20",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Coherus Oncology, Inc.",
"sponsor_slug": "coherus-oncology-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06266364",
"publication_url": "https://clinicaltrials.gov/study/NCT06266364",
"title": "Targeted Plasticity Therapy for the Treatment of Post-Traumatic Stress Disorder",
"has_exemption": false,
"start_date": "2024-12-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas at Dallas",
"sponsor_slug": "the-university-of-texas-at-dallas",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06660654",
"publication_url": "https://clinicaltrials.gov/study/NCT06660654",
"title": "REJOICE-PanTumor01: A Phase 2, Multicenter, Open-Label, Pan-Tumor Trial to Evaluate Efficacy and Safety of Raludotatug Deruxtecan (R-DXd) in Participants With Advanced/Metastatic Solid Tumors",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06754462",
"publication_url": "https://clinicaltrials.gov/study/NCT06754462",
"title": "A Phase 2b, Multicenter, Double-blind, Placebo-controlled Randomized Withdrawal Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat, ACPA-Positive Rheumatoid Arthritis",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunovant Sciences GmbH",
"sponsor_slug": "immunovant-sciences-gmbh",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06499896",
"publication_url": "https://clinicaltrials.gov/study/NCT06499896",
"title": "Phase II Trial of Healthy-donor Derived Full-spectrum Microbiome Therapeutic MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC) (FMT-ELIMINATE)",
"has_exemption": false,
"start_date": "2025-01-23",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07090616",
"publication_url": "https://clinicaltrials.gov/study/NCT07090616",
"title": "A Randomized Controlled Trial of the KRONOS Versus Breg T-Scope Post-operative Knee Braces Following Anterior Cruciate Ligament (ACL) Reconstruction",
"has_exemption": false,
"start_date": "2025-02-11",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06823778",
"publication_url": "https://clinicaltrials.gov/study/NCT06823778",
"title": "Prophylactic Radiofrequency Left Atrial Posterior Wall Isolation (box Lesion Ablation) to Prevent Atrial Fibrillation After Cardiac Surgery (PROBOX): a Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-02-17",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vasily I. Kaleda",
"sponsor_slug": "vasily-i-kaleda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06773416",
"publication_url": "https://clinicaltrials.gov/study/NCT06773416",
"title": "Treating Sleep Apnea to Improve Cognitive Function, Alzheimer's Disease Pathology, and Astrocyte Activation in Older Adults With Cognitive Impairment: A Multi-Centre Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-02-28",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sunnybrook Health Sciences Centre",
"sponsor_slug": "sunnybrook-health-sciences-centre",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06892639",
"publication_url": "https://clinicaltrials.gov/study/NCT06892639",
"title": "Evaluation of Dabocemagene Autoficel (D-Fi; FCX-007; Genetically Modified Autologous Human Dermal Fibroblasts) for the Treatment of Wounds Due to Dystropic Epidermolysis Bullosa",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Castle Creek Biosciences, LLC.",
"sponsor_slug": "castle-creek-biosciences-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06908733",
"publication_url": "https://clinicaltrials.gov/study/NCT06908733",
"title": "Prognosis and Patient-Reported Outcomes of Combined Local Treatments (Surgery and Radiotherapy or Radiotherapy Alone) With Tislelizumab and Chemotherapy in Initial Stage III-N3 Non-Small Cell Lung Cancer: A Prospective, Open-Label, Single-Arm, Phase II Trial",
"has_exemption": false,
"start_date": "2025-03-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Liaoning Cancer Hospital & Institute",
"sponsor_slug": "liaoning-cancer-hospital-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06080074",
"publication_url": "https://clinicaltrials.gov/study/NCT06080074",
"title": "Multicenter Trial to Evaluate the Safety and Effectiveness of the Cardiohelp System for up to 30 Days of Support in Children With Severe Cardiac Failure",
"has_exemption": false,
"start_date": "2025-04-15",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06881992",
"publication_url": "https://clinicaltrials.gov/study/NCT06881992",
"title": "A Phase 3, Single-Arm, Open-label, Pivotal Study to Evaluate the Efficacy and Safety of Ersodetug Compared to Baseline in Patients With Inadequately Controlled Hypoglycemia Due to Tumor Hyperinsulinism (Tumor HI)",
"has_exemption": false,
"start_date": "2025-04-16",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rezolute",
"sponsor_slug": "rezolute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948435",
"publication_url": "https://clinicaltrials.gov/study/NCT06948435",
"title": "A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06948422",
"publication_url": "https://clinicaltrials.gov/study/NCT06948422",
"title": "A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06952530",
"publication_url": "https://clinicaltrials.gov/study/NCT06952530",
"title": "A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Once Daily in Participants With Hypertension and Obesity or Overweight: Randomized, Double-Blind, Placebo-Controlled Trials (ATTAIN-HYPERTENSION)",
"has_exemption": false,
"start_date": "2025-04-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06966479",
"publication_url": "https://clinicaltrials.gov/study/NCT06966479",
"title": "A Long-Term Extension Study to Evaluate Safety and Efficacy of Verekitug (UPB-101) in Adult Participants With Severe Asthma Who Completed the VALIANT Trial",
"has_exemption": false,
"start_date": "2025-05-21",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Upstream Bio Inc.",
"sponsor_slug": "upstream-bio-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07035093",
"publication_url": "https://clinicaltrials.gov/study/NCT07035093",
"title": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain",
"has_exemption": false,
"start_date": "2025-05-29",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06521723",
"publication_url": "https://clinicaltrials.gov/study/NCT06521723",
"title": "Breathing Low Oxygen to Enhance Spinal Stimulation Training and Functional Recovery for Aging Adults With Chronic SCI: The BO2ST-II Trial",
"has_exemption": false,
"start_date": "2025-06-06",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Spaulding Rehabilitation Hospital",
"sponsor_slug": "spaulding-rehabilitation-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06891755",
"publication_url": "https://clinicaltrials.gov/study/NCT06891755",
"title": "Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3",
"has_exemption": false,
"start_date": "2025-07-15",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Apreo Health, Inc.",
"sponsor_slug": "apreo-health-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07106021",
"publication_url": "https://clinicaltrials.gov/study/NCT07106021",
"title": "A Phase 1b/2a Study Assessing the Safety and Efficacy of Intraputamenal Dopaminergic Stem Cell Transplants in Patients With Idiopathic Parkinson's Disease",
"has_exemption": false,
"start_date": "2025-07-17",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kenai Therapeutics",
"sponsor_slug": "kenai-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06468033",
"publication_url": "https://clinicaltrials.gov/study/NCT06468033",
"title": "A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Study to Assess Efficacy and Safety of Ropeginterferon Alfa-2b (P1101) in Adult Patients With Pre-fibrotic/Early Primary Myelofibrosis (PMF) or Overt PMF at Low or Intermediate-1 Risk According to DIPSS Plus (HOPE-PMF): The Core Study and Its Extension Study",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "PharmaEssentia",
"sponsor_slug": "pharmaessentia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06779630",
"publication_url": "https://clinicaltrials.gov/study/NCT06779630",
"title": "A Prospective Multicenter Single Arm Study to Assess the Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus-Eluting Coronary Stent System for the Treatment of Subjects With Atherosclerotic Lesion(s)",
"has_exemption": false,
"start_date": "2025-07-18",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Teleflex",
"sponsor_slug": "teleflex",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06513949",
"publication_url": "https://clinicaltrials.gov/study/NCT06513949",
"title": "Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Anti-CD14 Treatment With a Recombinant Chimeric Monoclonal Antibody (IC14) in Hospitalized Patients With Acute Respiratory Distress Syndrome",
"has_exemption": false,
"start_date": "2025-08-15",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Implicit Bioscience",
"sponsor_slug": "implicit-bioscience",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06868485",
"publication_url": "https://clinicaltrials.gov/study/NCT06868485",
"title": "A Phase II, Open Label, Multicenter, Single Arm Study of WSD0922-FU for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With First-Line Osimertinib Treatment and Harbor a C797S Mutation",
"has_exemption": false,
"start_date": "2025-08-18",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Wayshine Biopharm, Inc.",
"sponsor_slug": "wayshine-biopharm-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06920004",
"publication_url": "https://clinicaltrials.gov/study/NCT06920004",
"title": "A Phase 3, Randomized, Double-Blinded, Double-Dummy Study Evaluating the Efficacy and Safety of Intravenous Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy",
"has_exemption": false,
"start_date": "2025-08-22",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07053969",
"publication_url": "https://clinicaltrials.gov/study/NCT07053969",
"title": "The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness. A Randomized Controlled Trial.",
"has_exemption": false,
"start_date": "2025-08-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04752319",
"publication_url": "https://clinicaltrials.gov/study/NCT04752319",
"title": "BreEStim for Post-Stroke Motor Recovery",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06029062",
"publication_url": "https://clinicaltrials.gov/study/NCT06029062",
"title": "tACS Brain Neuromodulation for Sensory and Motor Recovery After Neurological Impairments",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06029075",
"publication_url": "https://clinicaltrials.gov/study/NCT06029075",
"title": "tACS Brain Neuromodulation for Sensory and Motor Recovery After Neurological Impairments",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center, Houston",
"sponsor_slug": "the-university-of-texas-health-science-center-houston",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07151391",
"publication_url": "https://clinicaltrials.gov/study/NCT07151391",
"title": "The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers",
"has_exemption": false,
"start_date": "2025-09-03",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05696561",
"publication_url": "https://clinicaltrials.gov/study/NCT05696561",
"title": "A Prospective, Multicenter, First in Human Clinical Trial to Evaluate the Safety and Effectiveness of the DF12 CANALOPLASTY AND TRABECULOTOMY SURGICAL SYSTEM in Subjects With Open-Angle Glaucoma Undergoing Cataract Surgery",
"has_exemption": false,
"start_date": "2025-09-09",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New World Medical, Inc.",
"sponsor_slug": "new-world-medical-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07082439",
"publication_url": "https://clinicaltrials.gov/study/NCT07082439",
"title": "Phase II Trial of Pembrolizumab in Combination With Odetiglucan for Patients With Metastatic Colorectal Adenocarcinoma With Liver Predominant Disease",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Abramson Cancer Center at Penn Medicine",
"sponsor_slug": "abramson-cancer-center-at-penn-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07192965",
"publication_url": "https://clinicaltrials.gov/study/NCT07192965",
"title": "ECG-less Coronary Computed Tomography Angiography in the Management of Patients Presenting With High-troponin Chest Pain",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Universitair Ziekenhuis Brussel",
"sponsor_slug": "universitair-ziekenhuis-brussel",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07193524",
"publication_url": "https://clinicaltrials.gov/study/NCT07193524",
"title": "Assessment of the Feasibility of Using a Preoperative Surgical Fracture Analysis Tool",
"has_exemption": false,
"start_date": "2025-09-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222371",
"publication_url": "https://clinicaltrials.gov/study/NCT07222371",
"title": "An Open-label, Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for TUBB4A-related Leukodystrophy",
"has_exemption": false,
"start_date": "2025-09-19",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07201389",
"publication_url": "https://clinicaltrials.gov/study/NCT07201389",
"title": "A Study to Investigate DigniCap Scalp Cooling on Black Patients for Prevention of Chemotherapy-induced Alopecia.",
"has_exemption": false,
"start_date": "2025-09-24",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "George Washington University",
"sponsor_slug": "george-washington-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07215936",
"publication_url": "https://clinicaltrials.gov/study/NCT07215936",
"title": "Dose_dense Capecitabine Schedule [7days on _7days Off] in Colorectal Cancer in Comparison With Standered Regimen",
"has_exemption": false,
"start_date": "2025-09-25",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Sohag University",
"sponsor_slug": "sohag-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06333171",
"publication_url": "https://clinicaltrials.gov/study/NCT06333171",
"title": "4-aminopyridine for Skin Wound Healing",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "John Elfar",
"sponsor_slug": "john-elfar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06559137",
"publication_url": "https://clinicaltrials.gov/study/NCT06559137",
"title": "Prospective Evaluation of Post-operative Pain Management Using Peripheral Nerve Blocks in the Pediatric Population",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Texas Scottish Rite Hospital for Children",
"sponsor_slug": "texas-scottish-rite-hospital-for-children",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06923527",
"publication_url": "https://clinicaltrials.gov/study/NCT06923527",
"title": "A Single Arm Phase II Trial of Circulating Tumor DNA-guided Adjuvant Therapy With Elacestrant in Adults With Hormone Receptor Positive HER2 Negative Breast Cancers at Risk for Late Recurrence (CATE)",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07115420",
"publication_url": "https://clinicaltrials.gov/study/NCT07115420",
"title": "Optimising EUS-guided Choledochoduodenostomy With Lumen Apposing Metal Stent With Stent in Stent Placement: a Randomised Study Between Double Pigtail Stent and Fully Covered Self-Expanding Metal Stent. The Opti-LAMS Study",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Waikato Hospital",
"sponsor_slug": "waikato-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07133893",
"publication_url": "https://clinicaltrials.gov/study/NCT07133893",
"title": "Effects of Transcranial Photobiomodulation and Attention Bias Modification on Anxiety Symptoms and Brain Hemodynamics",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Texas at Austin",
"sponsor_slug": "university-of-texas-at-austin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07138898",
"publication_url": "https://clinicaltrials.gov/study/NCT07138898",
"title": "Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07184021",
"publication_url": "https://clinicaltrials.gov/study/NCT07184021",
"title": "Neoadjuvent Dose-dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer:Results of a Phase 2 Trial",
"has_exemption": false,
"start_date": "2025-09-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Assiut University",
"sponsor_slug": "assiut-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07010614",
"publication_url": "https://clinicaltrials.gov/study/NCT07010614",
"title": "Theta Burst Modulation of Hippocampal-Cortical Rhythms in Schizophrenia",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07077278",
"publication_url": "https://clinicaltrials.gov/study/NCT07077278",
"title": "Effect of Low Sodium Oxybate (LXB) on Autonomic Symptom Burden in Idiopathic Hypersomnia Patients With Postural Tachycardia Syndrome: a Placebo-controlled, Double-blind, Randomized Withdrawal Study",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214545",
"publication_url": "https://clinicaltrials.gov/study/NCT07214545",
"title": "Phase IIa Clinical Trial of External Trigeminal Nerve Stimulation for Autistic Children With Attention Deficit/Hyperactivity Disorder",
"has_exemption": false,
"start_date": "2025-10-06",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07185425",
"publication_url": "https://clinicaltrials.gov/study/NCT07185425",
"title": "Management of Postoperative Pain After Cesarean Delivery Using Non-pharmacological Analgesic Device, NeuroCuple™",
"has_exemption": false,
"start_date": "2025-10-13",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Inova Health Care Services",
"sponsor_slug": "inova-health-care-services",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07191314",
"publication_url": "https://clinicaltrials.gov/study/NCT07191314",
"title": "Long-term Evaluation of a Nasopharyngeal Airway",
"has_exemption": false,
"start_date": "2025-10-21",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Michigan",
"sponsor_slug": "university-of-michigan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07229417",
"publication_url": "https://clinicaltrials.gov/study/NCT07229417",
"title": "IvoLoC Trial: A Phase II Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER2-negative or Triple Negative Invasive Lobular Carcinoma",
"has_exemption": false,
"start_date": "2025-10-22",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07189897",
"publication_url": "https://clinicaltrials.gov/study/NCT07189897",
"title": "An Open-label Pilot Study to Evaluate Medication Satisfaction With Apixaban Versus Enoxaparin for Thrombosis Prevention After Head and Neck Cancer Surgery",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kiranya Arnold",
"sponsor_slug": "kiranya-arnold",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07194265",
"publication_url": "https://clinicaltrials.gov/study/NCT07194265",
"title": "A Prospective Randomized Trial Assessing the Safety and Effectiveness of the DurAVR® Biomimetic Valve Designed for Physiologic Flow Compared to Commercial TAVR Devices",
"has_exemption": false,
"start_date": "2025-10-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Anteris Technologies Ltd.",
"sponsor_slug": "anteris-technologies-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07242118",
"publication_url": "https://clinicaltrials.gov/study/NCT07242118",
"title": "Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management",
"has_exemption": false,
"start_date": "2025-11-04",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Kansas Medical Center",
"sponsor_slug": "university-of-kansas-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990269",
"publication_url": "https://clinicaltrials.gov/study/NCT06990269",
"title": "A Phase 2, Randomized, Masked, Placebo-Controlled Study of Subcutaneously Administered ADX-038 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)",
"has_exemption": false,
"start_date": "2025-11-10",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "ADARx Pharmaceuticals, Inc.",
"sponsor_slug": "adarx-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287137",
"publication_url": "https://clinicaltrials.gov/study/NCT07287137",
"title": "IDCRP-154: Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study",
"has_exemption": false,
"start_date": "2025-11-12",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Henry M. Jackson Foundation for the Advancement of Military Medicine",
"sponsor_slug": "henry-m-jackson-foundation-for-the-advancement-of-military-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06940427",
"publication_url": "https://clinicaltrials.gov/study/NCT06940427",
"title": "Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis",
"has_exemption": false,
"start_date": "2025-11-19",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Wisconsin, Madison",
"sponsor_slug": "university-of-wisconsin-madison",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06559215",
"publication_url": "https://clinicaltrials.gov/study/NCT06559215",
"title": "Prospective Evaluation of Post-operative Pain Management Using Exparel in the Pediatric Population",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Texas Scottish Rite Hospital for Children",
"sponsor_slug": "texas-scottish-rite-hospital-for-children",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07200115",
"publication_url": "https://clinicaltrials.gov/study/NCT07200115",
"title": "Cervical Ripening Double Balloon Catheters Versus Osmotic Dilators For Cervical Preparation Before Dilation & Evacuation: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-12-03",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07276997",
"publication_url": "https://clinicaltrials.gov/study/NCT07276997",
"title": "A Phase 2, Multicenter, 6-Week, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Icalcaprant in Subjects With Major Depressive Disorder",
"has_exemption": false,
"start_date": "2025-12-18",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07087691",
"publication_url": "https://clinicaltrials.gov/study/NCT07087691",
"title": "Pilot Post-Marketing Study on the Efficacy of OneMark in Identifying Breast Cancer For Surgery and Over Time in High and Low Density Breast Tissue",
"has_exemption": false,
"start_date": "2025-12-22",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Diego",
"sponsor_slug": "university-of-california-san-diego",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07311850",
"publication_url": "https://clinicaltrials.gov/study/NCT07311850",
"title": "Evaluating The Efficacy and Safety of MET097, a Fully-Biased, Ultra Long-Acting GLP-1RA, In People With Overweight or Obesity: A Phase 3, Multi-Center Randomized, Controlled Trial (VESPER-4)",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Metsera, a wholly owned subsidiary of Pfizer",
"sponsor_slug": "metsera-a-wholly-owned-subsidiary-of-pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226141",
"publication_url": "https://clinicaltrials.gov/study/NCT07226141",
"title": "Valproate for the Treatment of Residual Amblyopia",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Children’s Hospital",
"sponsor_slug": "boston-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07384975",
"publication_url": "https://clinicaltrials.gov/study/NCT07384975",
"title": "A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study of NAV-240 in Adult Participants With Moderate-to-Severe Hidradenitis Suppurativa",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Navigator Medicines, Inc.",
"sponsor_slug": "navigator-medicines-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07332299",
"publication_url": "https://clinicaltrials.gov/study/NCT07332299",
"title": "Remote Stimulation and Training to Advance Recovery From TBI in Seniors",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Minneapolis Veterans Affairs Medical Center",
"sponsor_slug": "minneapolis-veterans-affairs-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07139106",
"publication_url": "https://clinicaltrials.gov/study/NCT07139106",
"title": "Dynorphin/Kappa Opioid Receptor Signaling Role in Ketamine's Anti-suicidal Ideation Effect",
"has_exemption": false,
"start_date": "2026-02-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "New York State Psychiatric Institute",
"sponsor_slug": "new-york-state-psychiatric-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06968845",
"publication_url": "https://clinicaltrials.gov/study/NCT06968845",
"title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability and Efficacy of Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03) in Patients With Idiopathic Pulmonary Fibrosis",
"has_exemption": false,
"start_date": "2026-02-02",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rein Therapeutics",
"sponsor_slug": "rein-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06716411",
"publication_url": "https://clinicaltrials.gov/study/NCT06716411",
"title": "Confirming the Effects of Acupuncture Treatments to Relieve Symptoms of Gulf War Illness",
"has_exemption": false,
"start_date": "2026-02-03",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07210723",
"publication_url": "https://clinicaltrials.gov/study/NCT07210723",
"title": "A Phase 2b/3, Adaptive, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy",
"has_exemption": false,
"start_date": "2026-02-13",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Kardigan, Inc.",
"sponsor_slug": "kardigan-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07169617",
"publication_url": "https://clinicaltrials.gov/study/NCT07169617",
"title": "Evaluating the Feasibility of a Survivin Peptide Vaccine (SurVaxM) as an Interception Agent in Patients at High Risk for Lung Cancer",
"has_exemption": false,
"start_date": "2026-02-25",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07225842",
"publication_url": "https://clinicaltrials.gov/study/NCT07225842",
"title": "The Bridging Antiplatelet Therapy With Cangrelor 2 (BRIDGE 2) Study: A Pilot Prospective Cohort, Pharmacodynamic Study of Tailored Cangrelor Bridging Dosing Regimens",
"has_exemption": false,
"start_date": "2026-02-25",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05237687",
"publication_url": "https://clinicaltrials.gov/study/NCT05237687",
"title": "Sirolimus in Older Adults- Randomized Trial Assessing the Improvement in Phenotypic/Functional Biomarkers of Aging",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Irina Timofte",
"sponsor_slug": "irina-timofte",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07278869",
"publication_url": "https://clinicaltrials.gov/study/NCT07278869",
"title": "Early Feasibility Study of the Append System for Left Atrial Appendage (LAA) Elimination by Invagination and Ligation",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Append Medical Ltd.",
"sponsor_slug": "append-medical-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07359820",
"publication_url": "https://clinicaltrials.gov/study/NCT07359820",
"title": "A Phase 2, Open-Label, Single-Arm Study of Lirafugratinib in Patients With Previously Treated, Unresectable, Locally Advanced or Metastatic Solid Tumors (Excluding Cholangiocarcinoma) With FGFR2 Fusion or Rearrangement",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Elevar Therapeutics",
"sponsor_slug": "elevar-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07451652",
"publication_url": "https://clinicaltrials.gov/study/NCT07451652",
"title": "Low Dose Epcoritamab Plus Gemcitabine/Oxaliplatin in Treatment of Transplant Eligible Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma",
"has_exemption": false,
"start_date": "2026-02-28",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Hospital Universitario Dr. Jose E. Gonzalez",
"sponsor_slug": "hospital-universitario-dr-jose-e-gonzalez",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222449",
"publication_url": "https://clinicaltrials.gov/study/NCT07222449",
"title": "Wearables-and Blood-based Biomarkers-incorporated Modernisation of Circadian Rhythm Disruption Management in People Living With Alzheimer's Dementia: A Stepwise Study From Digital Inclusivity, Digital Therapy, to Digital Phenotyping and Biomarker Exploration",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "China Medical University Hospital",
"sponsor_slug": "china-medical-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07145866",
"publication_url": "https://clinicaltrials.gov/study/NCT07145866",
"title": "Evaluation of Varenicline and Accelerated TMS for Reduction of Nicotine Use",
"has_exemption": false,
"start_date": "2026-03-15",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07143968",
"publication_url": "https://clinicaltrials.gov/study/NCT07143968",
"title": "A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of Resmetirom for the Treatment of Metabolic Dysfunction- Associated Steatotic Liver Disease (MASLD) in People Living With Human Immunodeficiency Virus (HIV)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Naga P. Chalasani",
"sponsor_slug": "naga-p-chalasani",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07296315",
"publication_url": "https://clinicaltrials.gov/study/NCT07296315",
"title": "A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Confirm Efficacy and Safety of MH002 and to Assess the Effect of Dose in Patients With Mild-to- Moderate Ulcerative Colitis Insufficiently Controlled With 5-Aminosalicylic Acid",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "MRM Health NV",
"sponsor_slug": "mrm-health-nv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07407023",
"publication_url": "https://clinicaltrials.gov/study/NCT07407023",
"title": "Randomized Clinical Trial of (PoRI) Post-Stroke Hand Rehabilitation Device",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07453888",
"publication_url": "https://clinicaltrials.gov/study/NCT07453888",
"title": "Randomized, Multicenter, Vehicle-Controlled, Double-Masked Phase 3 Study to Evaluate the Efficacy and Safety of Intranasal Cenegermin (Recombinant Human Nerve Growth Factor [rhNGF]) in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Dompé Farmaceutici S.p.A",
"sponsor_slug": "dompe-farmaceutici-spa",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07457567",
"publication_url": "https://clinicaltrials.gov/study/NCT07457567",
"title": "Neural and Behavioral Correlates of Live Face-to-Face Interactions",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07476001",
"publication_url": "https://clinicaltrials.gov/study/NCT07476001",
"title": "A Phase 2a Study of High Dose Testosterone Followed by Targeted Radioligand Therapy in Metastatic Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "H. Lee Moffitt Cancer Center and Research Institute",
"sponsor_slug": "h-lee-moffitt-cancer-center-and-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07477691",
"publication_url": "https://clinicaltrials.gov/study/NCT07477691",
"title": "A Phase 4 Study of Immune Modulation During Palynziq® Treatment in Adults With Phenylketonuria (PKU)",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07301125",
"publication_url": "https://clinicaltrials.gov/study/NCT07301125",
"title": "Myofunctional Therapy for Obstructive Sleep Apnea",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Minnesota",
"sponsor_slug": "university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07483320",
"publication_url": "https://clinicaltrials.gov/study/NCT07483320",
"title": "A Randomized Controlled Trial Evaluating the Influence of Physical Therapy, Shockwave Therapy, Platelet Rich Plasma or Combined Treatment in the Management of Midportion Achilles Tendinopathy",
"has_exemption": false,
"start_date": "2026-04-01",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Spaulding Rehabilitation Hospital",
"sponsor_slug": "spaulding-rehabilitation-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07377474",
"publication_url": "https://clinicaltrials.gov/study/NCT07377474",
"title": "A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism With Sphere Between 0.00D and -1.00D",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Bausch & Lomb Incorporated",
"sponsor_slug": "bausch-lomb-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07436611",
"publication_url": "https://clinicaltrials.gov/study/NCT07436611",
"title": "Rapamycin Dose-Ranging Efficacy Study: A Phase II, Proof of Concept, Double-blind, Placebo-controlled, Randomized, Parallel-group, Dose-response Comparison of the Effects of Different Strengths of Rapamycin Cream Applied Topically in Subjects Diagnosed With Port Wine Stains",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "AFT Pharmaceuticals, Ltd.",
"sponsor_slug": "aft-pharmaceuticals-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05731050",
"publication_url": "https://clinicaltrials.gov/study/NCT05731050",
"title": "A Phase II, Open Label, Multi Dose Study of NM8074 in Soliris-Treated Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "NovelMed Therapeutics",
"sponsor_slug": "novelmed-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03171129",
"publication_url": "https://clinicaltrials.gov/study/NCT03171129",
"title": "Adaptive Dynamic Inspiratory Nasal Apparatus (ADINA): Comparison to High Flow Nasal Cannula (HFNC)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Loma Linda University",
"sponsor_slug": "loma-linda-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07457164",
"publication_url": "https://clinicaltrials.gov/study/NCT07457164",
"title": "A Phase 2, Open-Label, Single-Arm, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2027-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Antev Ltd.",
"sponsor_slug": "antev-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03674697",
"publication_url": "https://clinicaltrials.gov/study/NCT03674697",
"title": "The Effect of Light Therapy on Post-Surgical Pain",
"has_exemption": false,
"start_date": "2018-09-05",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Arizona",
"sponsor_slug": "university-of-arizona",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04025372",
"publication_url": "https://clinicaltrials.gov/study/NCT04025372",
"title": "INTREPId (INTermediate Risk Erection PreservatIon Trial): A Randomized Trial of Radiation Therapy and Darolutamide for Prostate Cancer",
"has_exemption": false,
"start_date": "2020-06-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Brigham and Women's Hospital",
"sponsor_slug": "brigham-and-womens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04828798",
"publication_url": "https://clinicaltrials.gov/study/NCT04828798",
"title": "Directional Versus Nondirectional Deep Brain Stimulation of the VIM Thalamic Nucleus for Essential Tremor: Assessment of Therapeutic Window, Speech, Gait and Balance",
"has_exemption": false,
"start_date": "2021-04-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Oregon Health and Science University",
"sponsor_slug": "oregon-health-and-science-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05070845",
"publication_url": "https://clinicaltrials.gov/study/NCT05070845",
"title": "AN INTERVENTIONAL PHASE 2, OPEN-LABEL, MULTI-CENTER STUDY TO EVALUATE SAFETY AND EFFICACY OF PF-06835375 IN ADULT PARTICIPANTS WITH MODERATE TO SEVERE PRIMARY IMMUNE THROMBOCYTOPENIA",
"has_exemption": false,
"start_date": "2022-02-02",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05010590",
"publication_url": "https://clinicaltrials.gov/study/NCT05010590",
"title": "Anabolic Therapy in Postmenopausal Osteoporosis",
"has_exemption": false,
"start_date": "2022-03-24",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Massachusetts General Hospital",
"sponsor_slug": "massachusetts-general-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04605913",
"publication_url": "https://clinicaltrials.gov/study/NCT04605913",
"title": "A Phase I/Ib Pilot Trial, Single Arm, Open Label, of Protein-Bound Paclitaxel, Cisplatin, and Gemcitabine (GCN) Combined With Tumor Treatment Fields (TTF) in Patient With Metastatic Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2022-04-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05415072",
"publication_url": "https://clinicaltrials.gov/study/NCT05415072",
"title": "A Phase I/II, Multi-center, Open Label Study of DYP688 in Patients With Metastatic Uveal Melanoma (MUM) and Other GNAQ/11 Mutant Melanomas",
"has_exemption": false,
"start_date": "2022-07-04",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05068232",
"publication_url": "https://clinicaltrials.gov/study/NCT05068232",
"title": "A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer (DARES)",
"has_exemption": false,
"start_date": "2022-08-19",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05489211",
"publication_url": "https://clinicaltrials.gov/study/NCT05489211",
"title": "A Phase II, Multicentre, Open-label, Master Protocol to Evaluate the Efficacy and Safety of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination With Anticancer Agents in Patients With Advanced/Metastatic Solid Tumours",
"has_exemption": false,
"start_date": "2022-09-06",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05531084",
"publication_url": "https://clinicaltrials.gov/study/NCT05531084",
"title": "Safety and Effectiveness of Surgeon-Modified Fenestrated and Branched Endografts in Treating Subjects With Complex Aortic Aneurysms",
"has_exemption": false,
"start_date": "2022-10-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jesse Manunga, MD",
"sponsor_slug": "jesse-manunga-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04789044",
"publication_url": "https://clinicaltrials.gov/study/NCT04789044",
"title": "A Phase 2a Multicenter Randomized Controlled Trial Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion) Compared to Standard of Care in the Repair of Mixed Motor-sensory Acute Peripheral Nerve Injuries (PNI) for Rapid and Immediate Improvement in Outcome",
"has_exemption": false,
"start_date": "2023-06-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Major Extremity Trauma Research Consortium",
"sponsor_slug": "major-extremity-trauma-research-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05819138",
"publication_url": "https://clinicaltrials.gov/study/NCT05819138",
"title": "Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Colorado, Denver",
"sponsor_slug": "university-of-colorado-denver",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05996900",
"publication_url": "https://clinicaltrials.gov/study/NCT05996900",
"title": "Investigating the Neural Mechanisms of Repetitive Brain Stimulation With Invasive and Noninvasive Electrophysiology in Humans",
"has_exemption": false,
"start_date": "2023-09-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06047080",
"publication_url": "https://clinicaltrials.gov/study/NCT06047080",
"title": "A Phase III, Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Glofitamab (RO7082859) in Combination With Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma",
"has_exemption": false,
"start_date": "2023-09-18",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06065462",
"publication_url": "https://clinicaltrials.gov/study/NCT06065462",
"title": "Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100",
"has_exemption": false,
"start_date": "2023-11-10",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05950945",
"publication_url": "https://clinicaltrials.gov/study/NCT05950945",
"title": "A Phase 3b, Multicenter, Global, Interventional, Open-label Study of Trastuzumab Deruxtecan (T-DXd), an Anti-HER2-Antibody Drug Conjugate (ADC), in Subjects Who Have Unresectable and/or Metastatic HER2-low or HER2 Immunohistochemistry (IHC) 0 Breast Cancer (DESTINY-Breast15)",
"has_exemption": false,
"start_date": "2023-12-30",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Daiichi Sankyo",
"sponsor_slug": "daiichi-sankyo",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06235801",
"publication_url": "https://clinicaltrials.gov/study/NCT06235801",
"title": "A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia",
"has_exemption": false,
"start_date": "2024-05-22",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06449326",
"publication_url": "https://clinicaltrials.gov/study/NCT06449326",
"title": "Multimodal Image Analysis and Guidance of Neuromodulation for Trauma-Related Symptoms",
"has_exemption": false,
"start_date": "2024-06-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of New Mexico",
"sponsor_slug": "university-of-new-mexico",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06891807",
"publication_url": "https://clinicaltrials.gov/study/NCT06891807",
"title": "RobAR Study: Comparison of Image Based Robotic TKA vs Imageless Augmented Reality-Assisted TKA",
"has_exemption": false,
"start_date": "2024-07-18",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medisch Centrum Latem",
"sponsor_slug": "medisch-centrum-latem",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06567821",
"publication_url": "https://clinicaltrials.gov/study/NCT06567821",
"title": "Using Navigation to Improve Accuracy of Maxillary Balloon Sinusotomy",
"has_exemption": false,
"start_date": "2024-09-04",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Cedars-Sinai Medical Center",
"sponsor_slug": "cedars-sinai-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06668194",
"publication_url": "https://clinicaltrials.gov/study/NCT06668194",
"title": "A Randomized Clinical Trial Comparing the Effect of Force Magnitude on the Rate of Canine Retraction and Gingival Crevicular Fluid Proteome Profile",
"has_exemption": false,
"start_date": "2024-11-13",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "UConn Health",
"sponsor_slug": "uconn-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06526104",
"publication_url": "https://clinicaltrials.gov/study/NCT06526104",
"title": "Phase II Single Arm Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B Cirrhosis (STRIDE in CP-B)",
"has_exemption": false,
"start_date": "2024-12-02",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Texas Health Science Center at San Antonio",
"sponsor_slug": "the-university-of-texas-health-science-center-at-san-antonio",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06692452",
"publication_url": "https://clinicaltrials.gov/study/NCT06692452",
"title": "A Phase II Study of Tazemetostat in Combination With CHOP for Previously Untreated T Cell Lymphoma",
"has_exemption": false,
"start_date": "2024-12-24",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Eric Jacobsen, MD",
"sponsor_slug": "eric-jacobsen-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05726292",
"publication_url": "https://clinicaltrials.gov/study/NCT05726292",
"title": "A Randomized Phase II Trial of Neoadjuvant Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer",
"has_exemption": false,
"start_date": "2025-01-06",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Chicago",
"sponsor_slug": "university-of-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06581328",
"publication_url": "https://clinicaltrials.gov/study/NCT06581328",
"title": "A Phase 4 Study Evaluating Moderate to Severely Active Ulcerative Colitis or Crohn's Disease and the Use of Vedolizumab Subcutaneous Within a Community Setting",
"has_exemption": false,
"start_date": "2025-03-27",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06735820",
"publication_url": "https://clinicaltrials.gov/study/NCT06735820",
"title": "Early Phase Study to Evaluate the MEK Inhibitor Selumetinib With the MDM2 Inhibitor APG-115 in Patients With Neurofibromatosis Type 1 and Pre-malignant and Malignant Peripheral Nerve Sheath Tumors",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "AeRang Kim",
"sponsor_slug": "aerang-kim",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06961383",
"publication_url": "https://clinicaltrials.gov/study/NCT06961383",
"title": "A Double Blind, Randomized, Placebo Controlled Phase 2b Study to Evaluate the Safety and Clinical Efficacy of Treatment With the Autologous Cell Therapy Product, NG01, in Patients With Secondary Progressive Multiple Sclerosis",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "NeuroGenesis Ltd.",
"sponsor_slug": "neurogenesis-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07174947",
"publication_url": "https://clinicaltrials.gov/study/NCT07174947",
"title": "SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety: A Randomized Controlled Clinical Trial",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "First Affiliated Hospital of Wenzhou Medical University",
"sponsor_slug": "first-affiliated-hospital-of-wenzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07210775",
"publication_url": "https://clinicaltrials.gov/study/NCT07210775",
"title": "Topical Imiquimod for the Treatment of Oral Dysplastic Lesions With Clinical and Histologic Assessments",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07174453",
"publication_url": "https://clinicaltrials.gov/study/NCT07174453",
"title": "A Late Phase Randomized Open-Label Multi Cohort Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies",
"has_exemption": false,
"start_date": "2025-10-07",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Kansas Medical Center",
"sponsor_slug": "university-of-kansas-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07171112",
"publication_url": "https://clinicaltrials.gov/study/NCT07171112",
"title": "Smoking Cessation Treatment Escalation Among Patients With Recurrent Acute Pancreatitis and Chronic Pancreatitis",
"has_exemption": false,
"start_date": "2025-11-06",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07185724",
"publication_url": "https://clinicaltrials.gov/study/NCT07185724",
"title": "Balancing Comfort and Success: Post-retrieval Ketorolac in Fresh Embryo Transfers",
"has_exemption": false,
"start_date": "2025-11-08",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jessica D. Kresowik",
"sponsor_slug": "jessica-d-kresowik",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07049458",
"publication_url": "https://clinicaltrials.gov/study/NCT07049458",
"title": "A Phase I/IIa, Open-Label, Dose-Escalation and Cohort-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CHO-A04 in Subjects With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Cho Pharma Inc.",
"sponsor_slug": "cho-pharma-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07152379",
"publication_url": "https://clinicaltrials.gov/study/NCT07152379",
"title": "An Open-label, Controlled Phase 2 Study Assessing a Challenge Transfusion of INTERCEPT Pathogen Reduced Red Blood Cells (RBCs) in Subjects With or Without Pre-existing Antibodies to INTERCEPT RBCs",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Cerus Corporation",
"sponsor_slug": "cerus-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07024316",
"publication_url": "https://clinicaltrials.gov/study/NCT07024316",
"title": "A Phase I-II, N-of-1, Open-Label, Prospective Study to Evaluate the Efficacy and Safety of ATL-001 in Adult Patients With Congenital Erythropoietic Porphyria (CEP)",
"has_exemption": false,
"start_date": "2026-01-15",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Atlas Molecular Pharma",
"sponsor_slug": "atlas-molecular-pharma",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06041503",
"publication_url": "https://clinicaltrials.gov/study/NCT06041503",
"title": "A Phase II Multicenter Study of Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)",
"has_exemption": false,
"start_date": "2026-01-20",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06997198",
"publication_url": "https://clinicaltrials.gov/study/NCT06997198",
"title": "Identification, Assessment, and Treatment of Tardive Dyskinesia With Deutetrabenazine in Adults With Intellectual/Developmental Disabilities and Co-occurring Psychiatric and/or Behavioral Disorders",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospitals Cleveland Medical Center",
"sponsor_slug": "university-hospitals-cleveland-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214298",
"publication_url": "https://clinicaltrials.gov/study/NCT07214298",
"title": "A Phase I/II Study of Complement Inhibition in Pancreatic Ductal Adenocarcinoma",
"has_exemption": false,
"start_date": "2026-03-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07442058",
"publication_url": "https://clinicaltrials.gov/study/NCT07442058",
"title": "ACHIEVE: Accelerated and Extended-rTMS to Heighten Inhibitory Control Engagement in Veterans",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2027-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05404945",
"publication_url": "https://clinicaltrials.gov/study/NCT05404945",
"title": "Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above (cHL 001)",
"has_exemption": false,
"start_date": "2022-07-26",
"completion_date": "2027-10-03",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Virginia",
"sponsor_slug": "university-of-virginia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06679140",
"publication_url": "https://clinicaltrials.gov/study/NCT06679140",
"title": "AN INTERVENTIONAL EFFICACY AND SAFETY, PHASE 3, DOUBLE-BLIND, 2-ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED IBUZATRELVIR COMPARED WITH PLACEBO IN NON-HOSPITALIZED SYMPTOMATIC ADULT AND ADOLESCENT PARTICIPANTS WITH COVID-19 WHO ARE AT HIGH RISK OF PROGRESSING TO SEVERE ILLNESS",
"has_exemption": false,
"start_date": "2024-12-08",
"completion_date": "2027-10-03",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06562543",
"publication_url": "https://clinicaltrials.gov/study/NCT06562543",
"title": "A Single Arm Phase 4 Trial to Evaluate the Safety and Efficacy of Oral Fruquintinib in the Treatment of Refractory Metastatic Colorectal Cancer in Patients From Minority Populations Underrepresented in Prior Fruquintinib Studies",
"has_exemption": false,
"start_date": "2025-01-14",
"completion_date": "2027-10-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07160608",
"publication_url": "https://clinicaltrials.gov/study/NCT07160608",
"title": "Phase 2, Randomized, Double-Blind, Placebo-controlled, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Tarperprumig in Adult Participants With Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (I TRANSCEND)",
"has_exemption": false,
"start_date": "2025-11-26",
"completion_date": "2027-10-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07257484",
"publication_url": "https://clinicaltrials.gov/study/NCT07257484",
"title": "Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors",
"has_exemption": false,
"start_date": "2026-04-06",
"completion_date": "2027-10-06",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07091630",
"publication_url": "https://clinicaltrials.gov/study/NCT07091630",
"title": "A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of Empasiprubart IV in Adults With Chronic Inflammatory Demyelinating Polyneuropathy",
"has_exemption": false,
"start_date": "2025-09-16",
"completion_date": "2027-10-07",
"has_results": false,
"results_due": false,
"sponsor_name": "argenx",
"sponsor_slug": "argenx",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07125664",
"publication_url": "https://clinicaltrials.gov/study/NCT07125664",
"title": "A Two-center, Randomized, Double-blind, Placebo-controlled Study of Intravenous Plasma-purified Alpha-1 Antitrypsin for Hospitalized Patients With COPD Exacerbations (AECOPD Study)",
"has_exemption": false,
"start_date": "2025-10-01",
"completion_date": "2027-10-07",
"has_results": false,
"results_due": false,
"sponsor_name": "Fondazione IRCCS Policlinico San Matteo di Pavia",
"sponsor_slug": "fondazione-irccs-policlinico-san-matteo-di-pavia",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07357597",
"publication_url": "https://clinicaltrials.gov/study/NCT07357597",
"title": "A Phase IV, Open-Label, Single-Arm Study of Prophylaxis for Datopotamab Deruxtecan-related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer (TROPION-SWISH)",
"has_exemption": false,
"start_date": "2026-02-27",
"completion_date": "2027-10-09",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06524960",
"publication_url": "https://clinicaltrials.gov/study/NCT06524960",
"title": "A Phase 1/2 Prospective, Randomized, Double-blind, Placebo-controlled Multi-center Clinical Trial to Determine the Safety and Efficacy of Denosumab in Improving Beta Cell Function and Glycemic Control Among Patients With Type 1 Diabetes",
"has_exemption": false,
"start_date": "2024-09-03",
"completion_date": "2027-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06504459",
"publication_url": "https://clinicaltrials.gov/study/NCT06504459",
"title": "A Phase II Study of Venetoclax (ABT-199) in Combination With Cladribine and Low-Dose Cytarabine Alternating With Azacitidine Plus Venetoclax in Newly Diagnosed Monocytic AML and Active-Signaling Mutated AML",
"has_exemption": false,
"start_date": "2025-01-03",
"completion_date": "2027-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "OHSU Knight Cancer Institute",
"sponsor_slug": "ohsu-knight-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06744647",
"publication_url": "https://clinicaltrials.gov/study/NCT06744647",
"title": "A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of ALXN2030 in Adult Patients With Antibody-Mediated Rejection After Kidney Transplantation",
"has_exemption": false,
"start_date": "2025-03-07",
"completion_date": "2027-10-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Alexion Pharmaceuticals, Inc.",
"sponsor_slug": "alexion-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07108283",
"publication_url": "https://clinicaltrials.gov/study/NCT07108283",
"title": "A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Zasocitinib in Participants With Nonsegmental Vitiligo",
"has_exemption": false,
"start_date": "2025-11-03",
"completion_date": "2027-10-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07400653",
"publication_url": "https://clinicaltrials.gov/study/NCT07400653",
"title": "EVALUATING THE EFFICACY AND SAFETY OF MET097, A FULLY-BIASED ULTRA LONG-ACTING GLP-1RA, IN PEOPLE WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES: A PHASE 3, MULTI-CENTER RANDOMIZED PLACEBO-CONTROLLED TRIAL (VESPER-5)",
"has_exemption": false,
"start_date": "2026-02-12",
"completion_date": "2027-10-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05030428",
"publication_url": "https://clinicaltrials.gov/study/NCT05030428",
"title": "A Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT)",
"has_exemption": false,
"start_date": "2021-11-23",
"completion_date": "2027-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06307665",
"publication_url": "https://clinicaltrials.gov/study/NCT06307665",
"title": "A Randomized, Double-blind, Multicenter, Parallel-group, Phase IIIb 52 Week Study Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered as Needed in Participants 12 to < 18 Years of Age With Asthma (ACADIA)",
"has_exemption": false,
"start_date": "2024-05-20",
"completion_date": "2027-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "AstraZeneca",
"sponsor_slug": "astrazeneca",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07215234",
"publication_url": "https://clinicaltrials.gov/study/NCT07215234",
"title": "A Phase 1/2, Study to Evaluate the Safety, Tolerability, and Efficacy of One-time Intravitreal Dose of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration",
"has_exemption": false,
"start_date": "2025-10-09",
"completion_date": "2027-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07237100",
"publication_url": "https://clinicaltrials.gov/study/NCT07237100",
"title": "A Pilot Study of Mirdametinib in Patients With Advanced Melanoma With an NF1 Mutation",
"has_exemption": false,
"start_date": "2025-10-13",
"completion_date": "2027-10-13",
"has_results": false,
"results_due": false,
"sponsor_name": "Kevin Kim, MD",
"sponsor_slug": "kevin-kim-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05077735",
"publication_url": "https://clinicaltrials.gov/study/NCT05077735",
"title": "Stereotactic Biopsy Split-Course Radiation Therapy - Diffuse Midline Glioma (SPORT-DMG)",
"has_exemption": false,
"start_date": "2021-10-11",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05465954",
"publication_url": "https://clinicaltrials.gov/study/NCT05465954",
"title": "Efficacy and Safety Study of Neoadjuvant Efineptakin Alfa (NT-I7) and Pembrolizumab in Recurrent Glioblastoma",
"has_exemption": false,
"start_date": "2023-01-24",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05922930",
"publication_url": "https://clinicaltrials.gov/study/NCT05922930",
"title": "Phase I/II Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer",
"has_exemption": false,
"start_date": "2023-10-11",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06476704",
"publication_url": "https://clinicaltrials.gov/study/NCT06476704",
"title": "Phase 2 Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas",
"has_exemption": false,
"start_date": "2025-06-01",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Institut de Cancerologie Strasbourg Europe",
"sponsor_slug": "institut-de-cancerologie-strasbourg-europe",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07162194",
"publication_url": "https://clinicaltrials.gov/study/NCT07162194",
"title": "PRIMER (Prostate MRI With Machine LEarning vs. Radiologist) A Novel MRI-Based Machine Learning Approach vs Radiologist MRI Reading for Targeted Prostate Biopsy: A Non-Inferiority, Within-Person Randomized Controlled Trial for Prostate Cancer Detection",
"has_exemption": false,
"start_date": "2025-09-19",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Southern California",
"sponsor_slug": "university-of-southern-california",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07222852",
"publication_url": "https://clinicaltrials.gov/study/NCT07222852",
"title": "Cardiovascular Protection After Preeclampsia With Enalapril",
"has_exemption": false,
"start_date": "2025-11-15",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Women and Infants Hospital of Rhode Island",
"sponsor_slug": "women-and-infants-hospital-of-rhode-island",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07287397",
"publication_url": "https://clinicaltrials.gov/study/NCT07287397",
"title": "Phase 1/2 Investigation of Novel Experimental Regimen in Amyotrophic Lateral Sclerosis (Pioneer-ALS): An Open-Label, Uncontrolled, Multicenter Study to Assess the Safety and Tolerability of Two Doses of VTx-002",
"has_exemption": false,
"start_date": "2025-12-19",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Vector Y Therapeutics",
"sponsor_slug": "vector-y-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06202066",
"publication_url": "https://clinicaltrials.gov/study/NCT06202066",
"title": "A Phase II Study of Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) in Patients With Progressing Metastatic Neuroendocrine Carcinomas (NECs)",
"has_exemption": false,
"start_date": "2026-04-15",
"completion_date": "2027-10-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Roswell Park Cancer Institute",
"sponsor_slug": "roswell-park-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06112314",
"publication_url": "https://clinicaltrials.gov/study/NCT06112314",
"title": "A Phase 3 Randomized, Controlled Study of IMC-F106C Plus Nivolumab Versus Nivolumab Regimens in HLA-A*02:01-Positive Participants With Previously Untreated Advanced Melanoma (PRISM-MEL-301",
"has_exemption": false,
"start_date": "2024-06-05",
"completion_date": "2027-10-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunocore Ltd",
"sponsor_slug": "immunocore-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07071623",
"publication_url": "https://clinicaltrials.gov/study/NCT07071623",
"title": "A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis in Women",
"has_exemption": false,
"start_date": "2025-11-10",
"completion_date": "2027-10-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07227012",
"publication_url": "https://clinicaltrials.gov/study/NCT07227012",
"title": "AN INTERVENTIONAL OPEN-LABEL PHASE 1B/2 STUDY TO EVALUATE SAFETY, PHARMACOKINETICS, AND PRELIMINARY EFFICACY OF PF-08634404 AS MONOTHERAPY AND COMBINATION THERAPY IN ADULT PARTICIPANTS WITH UNRESECTABLE LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA",
"has_exemption": false,
"start_date": "2025-12-01",
"completion_date": "2027-10-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04747613",
"publication_url": "https://clinicaltrials.gov/study/NCT04747613",
"title": "An Open Label, Multicenter Roll-over Extension Program (REP) to Characterize the Long-term Safety and Tolerability of Iptacopan (LNP023) in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Completed PNH Phase 2 and Phase3 Studies With Iptacopan",
"has_exemption": false,
"start_date": "2021-07-27",
"completion_date": "2027-10-19",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05118854",
"publication_url": "https://clinicaltrials.gov/study/NCT05118854",
"title": "A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation",
"has_exemption": false,
"start_date": "2022-03-30",
"completion_date": "2027-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05545826",
"publication_url": "https://clinicaltrials.gov/study/NCT05545826",
"title": "Vibrotactile Coordinated Reset: A Treatment for Early Stage Parkinson's Disease",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2027-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06845319",
"publication_url": "https://clinicaltrials.gov/study/NCT06845319",
"title": "Anthracycline-Free Neoadjuvant Chemoimmunotherapy for Triple Negative Breast Cancer Patients With Cardiomyopathy or at an Elevated Risk of Cardiotoxicity (NeoCARD): A Response Adapted Single-arm Phase 2 Trial",
"has_exemption": false,
"start_date": "2025-10-20",
"completion_date": "2027-10-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02861573",
"publication_url": "https://clinicaltrials.gov/study/NCT02861573",
"title": "Phase Ib/II Trial of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-365)",
"has_exemption": false,
"start_date": "2016-11-17",
"completion_date": "2027-10-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05805605",
"publication_url": "https://clinicaltrials.gov/study/NCT05805605",
"title": "Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning (RIC) With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases",
"has_exemption": false,
"start_date": "2023-05-01",
"completion_date": "2027-10-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06656390",
"publication_url": "https://clinicaltrials.gov/study/NCT06656390",
"title": "A First-in-Human, Open-Label, Multi-Center Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ALK201 for Injection in Adult Participants With Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-10-24",
"completion_date": "2027-10-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai Allink Biotherapeutics Co., Ltd.",
"sponsor_slug": "shanghai-allink-biotherapeutics-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02133196",
"publication_url": "https://clinicaltrials.gov/study/NCT02133196",
"title": "A Phase II Study Using Autologous Young Tumor-Infiltrating Lymphocytes Derived From Patients With Non-Small Cell Lung Cancer Following Non-Myeloablative Lymphocyte Depleting Preparative Regimen",
"has_exemption": false,
"start_date": "2014-10-23",
"completion_date": "2027-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02332668",
"publication_url": "https://clinicaltrials.gov/study/NCT02332668",
"title": "A Phase I/II Study of Pembrolizumab (MK-3475) in Children With Advanced Melanoma or a PD-L1 Positive Advanced, Relapsed or Refractory Solid Tumor or Lymphoma (KEYNOTE-051)",
"has_exemption": false,
"start_date": "2015-03-18",
"completion_date": "2027-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05012371",
"publication_url": "https://clinicaltrials.gov/study/NCT05012371",
"title": "A Phase II Study of Lenvatinib Plus Everolimus Versus Cabozantinib in Patients With Metastatic Renal Cell Carcinoma That Progressed on A PD-1/PD-L1 Checkpoint Inhibitor",
"has_exemption": false,
"start_date": "2022-02-16",
"completion_date": "2027-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06966453",
"publication_url": "https://clinicaltrials.gov/study/NCT06966453",
"title": "A PHASE 1b/2, OPEN-LABEL, MULTICOHORT STUDY OF DISITAMAB VEDOTIN IN ADULTS WITH HER2 EXPRESSING ADVANCED BREAST CANCER",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2027-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06941870",
"publication_url": "https://clinicaltrials.gov/study/NCT06941870",
"title": "Prospective Interventional Study of Effectiveness of Efanesoctocog Alfa Prophylaxis on Synovial Hypertrophy in Patients With Hemophilia A",
"has_exemption": false,
"start_date": "2025-09-23",
"completion_date": "2027-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07403487",
"publication_url": "https://clinicaltrials.gov/study/NCT07403487",
"title": "A Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of RC1416 Injection in Adult Patients With Moderate to Severe Asthma",
"has_exemption": false,
"start_date": "2026-03-10",
"completion_date": "2027-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Nanjing RegeneCore Biotech Co., Ltd.",
"sponsor_slug": "nanjing-regenecore-biotech-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03326336",
"publication_url": "https://clinicaltrials.gov/study/NCT03326336",
"title": "A Phase 1/2a, Open-Label, Non-Randomized, Dose-Escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa",
"has_exemption": false,
"start_date": "2018-09-26",
"completion_date": "2027-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "GenSight Biologics",
"sponsor_slug": "gensight-biologics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06435312",
"publication_url": "https://clinicaltrials.gov/study/NCT06435312",
"title": "An Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Activity of Zilucoplan in Pediatric Study Participants With Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis",
"has_exemption": false,
"start_date": "2024-11-19",
"completion_date": "2027-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "UCB Biopharma SRL",
"sponsor_slug": "ucb-biopharma-srl",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06990880",
"publication_url": "https://clinicaltrials.gov/study/NCT06990880",
"title": "A Phase 1/2 First-Time-In-Human, Open-Label, Multicenter, Dose Escalation and Expansion Study of GSK5458514 PSMA Targeting T Cell Engager Alone or in Combination With Other Anti-Cancer Agents in Adult Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)",
"has_exemption": false,
"start_date": "2025-06-12",
"completion_date": "2027-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07166952",
"publication_url": "https://clinicaltrials.gov/study/NCT07166952",
"title": "Peripheral Nerve Stimulation With the SPRINT® System in Chronic Posterior Sacroiliac Joint Complex Pain",
"has_exemption": false,
"start_date": "2025-10-26",
"completion_date": "2027-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05923073",
"publication_url": "https://clinicaltrials.gov/study/NCT05923073",
"title": "A Phase 3, Multicenter, Randomized, Platform Study of p19 Inhibition of the IL-23 Pathway to Establish Efficacy in Pediatric Crohn's Disease",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2027-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07223645",
"publication_url": "https://clinicaltrials.gov/study/NCT07223645",
"title": "Handgrip Training and Brain Blood Flow Regulation",
"has_exemption": false,
"start_date": "2025-10-27",
"completion_date": "2027-10-27",
"has_results": false,
"results_due": false,
"sponsor_name": "Florida State University",
"sponsor_slug": "florida-state-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04624204",
"publication_url": "https://clinicaltrials.gov/study/NCT04624204",
"title": "A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Pembrolizumab (MK-3475) in Combination With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib (MK-7339), Compared to Concurrent Chemoradiation Therapy Alone in Participants With Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC)",
"has_exemption": false,
"start_date": "2020-12-08",
"completion_date": "2027-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05672108",
"publication_url": "https://clinicaltrials.gov/study/NCT05672108",
"title": "Phase II Trial of Lung Chemoemobolization",
"has_exemption": false,
"start_date": "2023-05-12",
"completion_date": "2027-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "City of Hope Medical Center",
"sponsor_slug": "city-of-hope-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06090539",
"publication_url": "https://clinicaltrials.gov/study/NCT06090539",
"title": "A Phase 1/2, Multi-Center, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of BMS-986458, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed/Refractory Non-Hodgkin Lymphomas (R/R NHL)",
"has_exemption": false,
"start_date": "2023-12-29",
"completion_date": "2027-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Bristol-Myers Squibb",
"sponsor_slug": "bristol-myers-squibb",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06293053",
"publication_url": "https://clinicaltrials.gov/study/NCT06293053",
"title": "A Multicenter Open-label Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis",
"has_exemption": false,
"start_date": "2024-05-15",
"completion_date": "2027-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06452277",
"publication_url": "https://clinicaltrials.gov/study/NCT06452277",
"title": "A Phase 3 Open-label, Randomized, Active-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Orally Administered BAY 2927088 Compared With Standard of Care as a First-line Therapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With HER2-activating Mutations",
"has_exemption": false,
"start_date": "2024-08-28",
"completion_date": "2027-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Bayer",
"sponsor_slug": "bayer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06959771",
"publication_url": "https://clinicaltrials.gov/study/NCT06959771",
"title": "Base Editing Hematopoietic Stem Cell and BE T Cell Gene Therapy for CD40L-HyperIgM Syndrome-Single Patient Study",
"has_exemption": false,
"start_date": "2025-07-16",
"completion_date": "2027-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07463183",
"publication_url": "https://clinicaltrials.gov/study/NCT07463183",
"title": "A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-8690 in Adult Participants With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2026-03-30",
"completion_date": "2027-10-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02843945",
"publication_url": "https://clinicaltrials.gov/study/NCT02843945",
"title": "Initial Feasibility Study to Evaluate the Safety and Efficacy of the Permanently Implantable LDR CivaSheet® in Combination With External Beam Radiation in the Treatment of Pancreatic Cancer",
"has_exemption": false,
"start_date": "2017-05-31",
"completion_date": "2027-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "CivaTech Oncology",
"sponsor_slug": "civatech-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05584124",
"publication_url": "https://clinicaltrials.gov/study/NCT05584124",
"title": "Neuromodulation for Rehabilitation of Post-Stroke Fatigue: An rTMS Pilot Study",
"has_exemption": false,
"start_date": "2023-04-10",
"completion_date": "2027-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06680661",
"publication_url": "https://clinicaltrials.gov/study/NCT06680661",
"title": "ABBA CORD: Double Umbilical Cord Blood Transplants With Abatacept for Graft Versus Host Disease Prophylaxis",
"has_exemption": false,
"start_date": "2025-02-25",
"completion_date": "2027-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Leland Metheny",
"sponsor_slug": "leland-metheny",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06117254",
"publication_url": "https://clinicaltrials.gov/study/NCT06117254",
"title": "Evaluating Device-based Rehabilitation for Veterans With Functional Hearing Difficulties: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2025-03-09",
"completion_date": "2027-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "VA Office of Research and Development",
"sponsor_slug": "va-office-of-research-and-development",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06840392",
"publication_url": "https://clinicaltrials.gov/study/NCT06840392",
"title": "A Randomized, Double-blind, Double-dummy, Placebo-controlled, Multicenter, Phase 3 Study Assessing the Efficacy, Safety, and Tolerability of 2 Doses of Remibrutinib Over a 68-week Treatment Period in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE-2)",
"has_exemption": false,
"start_date": "2025-03-20",
"completion_date": "2027-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07099898",
"publication_url": "https://clinicaltrials.gov/study/NCT07099898",
"title": "Phase 3, Multicenter, Randomized, Open-label Clinical Study of GSK5764227, a B7-H3 Antibody Drug Conjugate (ADC), Compared With Topotecan in Participants With Relapsed Small Cell Lung Cancer (SCLC)",
"has_exemption": false,
"start_date": "2025-08-11",
"completion_date": "2027-10-29",
"has_results": false,
"results_due": false,
"sponsor_name": "GlaxoSmithKline",
"sponsor_slug": "glaxosmithkline",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03763162",
"publication_url": "https://clinicaltrials.gov/study/NCT03763162",
"title": "A Phase 2 Study of Daratumumab, Bortezomib, and Dexamethasone (DVd), Followed by Daratumumab, Ixazomib, and Dexamethasone (DId) for Relapsed and/or Refractory Myeloma",
"has_exemption": false,
"start_date": "2019-01-17",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04752774",
"publication_url": "https://clinicaltrials.gov/study/NCT04752774",
"title": "An Integrated Phase I/II, Multicentre, Double-blind, Randomised, Dysport and Placebo-controlled, Dose Escalation and Dose-finding Study to Evaluate the Safety and Efficacy of IPN10200 in the Treatment of Adult Upper Limb Spasticity.",
"has_exemption": false,
"start_date": "2021-04-29",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Ipsen",
"sponsor_slug": "ipsen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05018286",
"publication_url": "https://clinicaltrials.gov/study/NCT05018286",
"title": "An Open-label Extension Trial to Evaluate the Long-term Safety of Apraglutide in Short Bowel Syndrome.",
"has_exemption": false,
"start_date": "2021-07-13",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "VectivBio AG",
"sponsor_slug": "vectivbio-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04940286",
"publication_url": "https://clinicaltrials.gov/study/NCT04940286",
"title": "Phase II Study of Neoadjuvant Gemcitabine, Nab-paclitaxel, Durvalumab (MEDI4736) (Anti-PD-L1), and Oleclumab (Anti-CD73) in the Treatment of Resectable/Borderline Resectable Primary Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2021-09-28",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05663710",
"publication_url": "https://clinicaltrials.gov/study/NCT05663710",
"title": "Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC",
"has_exemption": false,
"start_date": "2023-06-30",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05874401",
"publication_url": "https://clinicaltrials.gov/study/NCT05874401",
"title": "A Randomized, Double-Blind, Placebo-Controlled Study of Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan Chemotherapy",
"has_exemption": false,
"start_date": "2023-10-18",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Pharmacosmos A/S",
"sponsor_slug": "pharmacosmos-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05922904",
"publication_url": "https://clinicaltrials.gov/study/NCT05922904",
"title": "PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma",
"has_exemption": false,
"start_date": "2023-12-14",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05970172",
"publication_url": "https://clinicaltrials.gov/study/NCT05970172",
"title": "A Phase 3, Open-label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Treatment of Anemia in Pediatric Participants With Chronic Kidney Disease",
"has_exemption": false,
"start_date": "2024-01-16",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Pharma Global Development, Inc.",
"sponsor_slug": "astellas-pharma-global-development-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05945355",
"publication_url": "https://clinicaltrials.gov/study/NCT05945355",
"title": "Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)",
"has_exemption": false,
"start_date": "2024-08-01",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06596135",
"publication_url": "https://clinicaltrials.gov/study/NCT06596135",
"title": "Open-Label Extension Study of Setmelanotide in Patients With a Rare Genetic, Syndromic or Acquired Disease of the MC4R Pathway",
"has_exemption": false,
"start_date": "2024-10-21",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Rhythm Pharmaceuticals, Inc.",
"sponsor_slug": "rhythm-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06220474",
"publication_url": "https://clinicaltrials.gov/study/NCT06220474",
"title": "Therapeutic Efficacy and Safety of Non-Invasive Radiofrequency Treatment in Patients With Refractory Meibomian Gland Dysfunction: A Randomized Controlled Trial",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "The University of Hong Kong",
"sponsor_slug": "the-university-of-hong-kong",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06686108",
"publication_url": "https://clinicaltrials.gov/study/NCT06686108",
"title": "Safety and Efficacy Study of Demethylating Agents With Venetoclax in Preventing Recurrence of High-risk T-cell Lymphoblastic Lymphoma/Leukemia After Transplantation",
"has_exemption": false,
"start_date": "2024-10-30",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine",
"sponsor_slug": "shanghai-general-hospital-shanghai-jiao-tong-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07043400",
"publication_url": "https://clinicaltrials.gov/study/NCT07043400",
"title": "A Phase 3, Multi-Center, Randomized, Open-Label Clinical Study of Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma",
"has_exemption": false,
"start_date": "2025-08-27",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07076082",
"publication_url": "https://clinicaltrials.gov/study/NCT07076082",
"title": "Vascular Trial Associated Registry Pilot: Antiplatelet Therapies for Patients Undergoing Lower Extremity Endovascular Revascularization",
"has_exemption": false,
"start_date": "2025-10-15",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Corewell Health West",
"sponsor_slug": "corewell-health-west",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06967558",
"publication_url": "https://clinicaltrials.gov/study/NCT06967558",
"title": "The Role of Islet GLP-1 in the Pathogenesis of Prediabetes",
"has_exemption": false,
"start_date": "2025-11-01",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07466745",
"publication_url": "https://clinicaltrials.gov/study/NCT07466745",
"title": "Autus Size-Adjustable Valve for Surgical Pulmonary Valve Replacement Continued Access Study",
"has_exemption": false,
"start_date": "2026-04-15",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Autus Valve Technologies, Inc.",
"sponsor_slug": "autus-valve-technologies-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07285616",
"publication_url": "https://clinicaltrials.gov/study/NCT07285616",
"title": "Optimizing Graft Selection in Glaucoma Surgery",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2027-10-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alberta",
"sponsor_slug": "university-of-alberta",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01208389",
"publication_url": "https://clinicaltrials.gov/study/NCT01208389",
"title": "A Follow-On Study to Evaluate the Safety of Re-Administration of Adeno-Associated Viral Vector Containing the Gene for Human RPE65 [AAV2-hRPE65v2] to the Contralateral Eye in Subjects With Leber Congenital Amaurosis (LCA) Previously Enrolled in a Phase 1 Study",
"has_exemption": false,
"start_date": "2010-11-30",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Spark Therapeutics, Inc.",
"sponsor_slug": "spark-therapeutics-inc",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01424982",
"publication_url": "https://clinicaltrials.gov/study/NCT01424982",
"title": "Phase II Study of Combination of Hyper-CVAD and Ponatinib in Patients With Philadelphia (PH) Chromosome Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)",
"has_exemption": false,
"start_date": "2011-10-05",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01696734",
"publication_url": "https://clinicaltrials.gov/study/NCT01696734",
"title": "Treatment Protocol for the Compassionate Use of Domperidone",
"has_exemption": false,
"start_date": "2012-10-23",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01720836",
"publication_url": "https://clinicaltrials.gov/study/NCT01720836",
"title": "Study of the Immunogenicity of the MUC1 Peptide - Poly-ICLC (Polyinosinic-polycytidylic Acid Stabilized With Polylysine and Carboxymethylcellulose) OR HILTONOL™ Adjuvant Vaccine in Patients With Localized and Locally Advanced Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2012-11-30",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Olivera Finn",
"sponsor_slug": "olivera-finn",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT01797523",
"publication_url": "https://clinicaltrials.gov/study/NCT01797523",
"title": "A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma",
"has_exemption": false,
"start_date": "2013-10-07",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02043691",
"publication_url": "https://clinicaltrials.gov/study/NCT02043691",
"title": "Evaluation of All-Cause Mortality and Pulmonary Morbidity in Treating Juxtarenal, Suprarenal, Thoracoabdominal, and Aortic Arch Pathologies Using Cook Custom Aortic Endografts, the Zenith t-Branch Endovascular Graft, and the Surgeon-Modified Endograft",
"has_exemption": false,
"start_date": "2014-06-30",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Alabama at Birmingham",
"sponsor_slug": "university-of-alabama-at-birmingham",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02250937",
"publication_url": "https://clinicaltrials.gov/study/NCT02250937",
"title": "Allogeneic Transplantation Using Venetoclax, Timed Sequential Busulfan,Cladribine, and Fludarabine Conditioning in Patients With AML and MDS",
"has_exemption": false,
"start_date": "2014-10-27",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02876107",
"publication_url": "https://clinicaltrials.gov/study/NCT02876107",
"title": "A Randomized Phase II Study of Neoadjuvant Carboplatin/Paclitaxel (CT) Versus Panitumumab/Carboplatin/Paclitaxel (PaCT) Followed by Anthracycline-Containing Regimen for Newly Diagnosed Primary Triple-Negative Inflammatory Breast Cancer",
"has_exemption": false,
"start_date": "2016-10-06",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03307616",
"publication_url": "https://clinicaltrials.gov/study/NCT03307616",
"title": "Phase II Study of Neoadjuvant Checkpoint Blockade in Patients With Surgically Resectable Undifferentiated Pleomorphic Sarcoma and Dedifferentiated Liposarcoma",
"has_exemption": false,
"start_date": "2017-10-04",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03359954",
"publication_url": "https://clinicaltrials.gov/study/NCT03359954",
"title": "PRECISE: Preoperative Radiotherapy to Elicit Critical Immune Stimulating Effects",
"has_exemption": false,
"start_date": "2017-11-16",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04040062",
"publication_url": "https://clinicaltrials.gov/study/NCT04040062",
"title": "Pilot Study: Evaluating the Feasibility of Repetitive Transcranial Magnetic Stimulation Treatment Delivered at Individual-based, SCC-determined Frequency in Subjects Suffering From Major Depressive Disorder",
"has_exemption": false,
"start_date": "2019-06-25",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04133675",
"publication_url": "https://clinicaltrials.gov/study/NCT04133675",
"title": "A Single-Blind, Randomized Study of the BTL EmsellaTM Chair Versus Sham for the Treatment of Stress Urinary Incontinence",
"has_exemption": false,
"start_date": "2019-12-18",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Corewell Health East",
"sponsor_slug": "corewell-health-east",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03915431",
"publication_url": "https://clinicaltrials.gov/study/NCT03915431",
"title": "A Phase 1/2 Randomized Study to Evaluate the Safety and Tolerability of Intracarotid Artery Administration of NCS-01 in Patients With Acute Ischemic Stroke",
"has_exemption": false,
"start_date": "2020-02-27",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NC Medial Research Inc",
"sponsor_slug": "nc-medial-research-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04563507",
"publication_url": "https://clinicaltrials.gov/study/NCT04563507",
"title": "CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer",
"has_exemption": false,
"start_date": "2020-11-12",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04570423",
"publication_url": "https://clinicaltrials.gov/study/NCT04570423",
"title": "A Multicenter, Open-Label, Phase 2 Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Patients With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy",
"has_exemption": false,
"start_date": "2021-05-20",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Spectrum Pharmaceuticals, Inc",
"sponsor_slug": "spectrum-pharmaceuticals-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04858334",
"publication_url": "https://clinicaltrials.gov/study/NCT04858334",
"title": "APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation",
"has_exemption": false,
"start_date": "2021-06-22",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04946370",
"publication_url": "https://clinicaltrials.gov/study/NCT04946370",
"title": "Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer",
"has_exemption": false,
"start_date": "2021-08-12",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04989803",
"publication_url": "https://clinicaltrials.gov/study/NCT04989803",
"title": "A Phase 1/2 Open-label, Multicenter Study Evaluating the Safety and Efficacy of KITE-363 or KITE-753, Autologous Anti-CD19/CD20 CAR T-cell Therapies, in Subjects With Relapsed and/or Refractory B-cell Lymphoma",
"has_exemption": false,
"start_date": "2021-10-27",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Kite, A Gilead Company",
"sponsor_slug": "kite-a-gilead-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04851717",
"publication_url": "https://clinicaltrials.gov/study/NCT04851717",
"title": "A Phase 2/3, Prospective, Open-label Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of Remimazolam for Intravenous Sedation in Paediatric Patients Undergoing Diagnostic and/or Therapeutic Procedures",
"has_exemption": false,
"start_date": "2021-11-15",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Acacia Pharma Ltd",
"sponsor_slug": "acacia-pharma-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04852328",
"publication_url": "https://clinicaltrials.gov/study/NCT04852328",
"title": "Non-Randomized Phase 2 Trial of Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma",
"has_exemption": false,
"start_date": "2021-12-06",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04573023",
"publication_url": "https://clinicaltrials.gov/study/NCT04573023",
"title": "A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)",
"has_exemption": false,
"start_date": "2022-02-14",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "JCR Pharmaceuticals Co., Ltd.",
"sponsor_slug": "jcr-pharmaceuticals-co-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04566991",
"publication_url": "https://clinicaltrials.gov/study/NCT04566991",
"title": "Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (DISH)",
"has_exemption": false,
"start_date": "2022-03-20",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Aditya S. Pandey, MD",
"sponsor_slug": "aditya-s-pandey-md",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04898010",
"publication_url": "https://clinicaltrials.gov/study/NCT04898010",
"title": "Investigator Initiated Pilot Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device (SCD) to Treat ICU Patients With Acute Kidney Injury (AKI) and Hepatorenal Syndrome (HRS) Type I",
"has_exemption": false,
"start_date": "2022-06-09",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lenar Yessayan",
"sponsor_slug": "lenar-yessayan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04741646",
"publication_url": "https://clinicaltrials.gov/study/NCT04741646",
"title": "Phosphate Binder Therapy and Chronic Kidney Disease in Children",
"has_exemption": false,
"start_date": "2022-06-17",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05312671",
"publication_url": "https://clinicaltrials.gov/study/NCT05312671",
"title": "Atezolizumab With Platinum and Etoposide Chemotherapy Followed by Cystectomy for Patients With Localized Small Cell Neuroendocrine Bladder Cancer",
"has_exemption": false,
"start_date": "2022-06-27",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
"sponsor_slug": "sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05301816",
"publication_url": "https://clinicaltrials.gov/study/NCT05301816",
"title": "A Post-Market, Multicenter, Prospective, Global Clinical Study to Evaluate the Real-world Experience of Spinal Cord Stimulation That Includes 10 kHz in the Management of Chronic Intractable Pain Associated With Diabetic Neuropathy.",
"has_exemption": false,
"start_date": "2022-07-05",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nevro Corp",
"sponsor_slug": "nevro-corp",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05296798",
"publication_url": "https://clinicaltrials.gov/study/NCT05296798",
"title": "A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Giredestrant in Combination With Phesgo Versus Phesgo After Induction Therapy With Phesgo + Taxane in Patients With Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally-Advanced or Metastatic Breast Cancer",
"has_exemption": false,
"start_date": "2022-07-18",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05384535",
"publication_url": "https://clinicaltrials.gov/study/NCT05384535",
"title": "Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort",
"has_exemption": false,
"start_date": "2022-08-15",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05570253",
"publication_url": "https://clinicaltrials.gov/study/NCT05570253",
"title": "\"A Phase 2, Double Blinded, Randomized Controlled Trial of Evexomostat (SDX-7320) or Placebo in Combination With Eribulin for Patients With Metastatic Triple-Negative Breast Cancer and Metabolic Dysfunction: The ARETHA Study",
"has_exemption": false,
"start_date": "2022-10-03",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Memorial Sloan Kettering Cancer Center",
"sponsor_slug": "memorial-sloan-kettering-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05514054",
"publication_url": "https://clinicaltrials.gov/study/NCT05514054",
"title": "EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer With an Increased Risk of Recurrence",
"has_exemption": false,
"start_date": "2022-10-04",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05317806",
"publication_url": "https://clinicaltrials.gov/study/NCT05317806",
"title": "Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient Population",
"has_exemption": false,
"start_date": "2022-10-10",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Indiana Hemophilia &Thrombosis Center, Inc.",
"sponsor_slug": "indiana-hemophilia-thrombosis-center-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05556512",
"publication_url": "https://clinicaltrials.gov/study/NCT05556512",
"title": "A Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Investigate the Effect of Tirzepatide on the Reduction of Morbidity and Mortality in Adults With Obesity",
"has_exemption": false,
"start_date": "2022-10-11",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eli Lilly and Company",
"sponsor_slug": "eli-lilly-and-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03887481",
"publication_url": "https://clinicaltrials.gov/study/NCT03887481",
"title": "Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Aphasic AD (Logopenic Variant PPA)",
"has_exemption": false,
"start_date": "2022-10-15",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins University",
"sponsor_slug": "johns-hopkins-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05256225",
"publication_url": "https://clinicaltrials.gov/study/NCT05256225",
"title": "A Phase II/III Study of Paclitaxel/Carboplatin Alone or Combined With Either Trastuzumab and Hyaluronidase-oysk (HERCEPTIN HYLECTA) or Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (PHESGO) in HER2 Positive, Stage I-IV Endometrial Serous Carcinoma or Carcinosarcoma",
"has_exemption": false,
"start_date": "2022-11-16",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05492799",
"publication_url": "https://clinicaltrials.gov/study/NCT05492799",
"title": "Open-Label Multicenter Extension Study to Further Evaluate Safety, Tolerability and Efficacy of Intracerebroventricular AX 250 Treatment in Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B) Patients",
"has_exemption": false,
"start_date": "2022-12-02",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Allievex Corporation",
"sponsor_slug": "allievex-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05650229",
"publication_url": "https://clinicaltrials.gov/study/NCT05650229",
"title": "An Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled, Flexible-dose, Adaptive Study of the Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease",
"has_exemption": false,
"start_date": "2022-12-13",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Abliva AB",
"sponsor_slug": "abliva-ab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05640947",
"publication_url": "https://clinicaltrials.gov/study/NCT05640947",
"title": "Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass: a Proof of Concent Study",
"has_exemption": false,
"start_date": "2023-01-30",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University Hospital, Ghent",
"sponsor_slug": "university-hospital-ghent",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02616302",
"publication_url": "https://clinicaltrials.gov/study/NCT02616302",
"title": "A Phase 2, Double-Blind, 12-Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules in Pediatric Subjects Aged 2 to 11 Years With Symptomatic Nonerosive Gastroesophageal Reflux Disease",
"has_exemption": false,
"start_date": "2023-02-20",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05644496",
"publication_url": "https://clinicaltrials.gov/study/NCT05644496",
"title": "A Randomized Controlled Trial of ZYNRELEF Versus Standard of Care for Pain Management Following Unilateral Total Knee Arthroplasty",
"has_exemption": false,
"start_date": "2023-03-09",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Baptist Health South Florida",
"sponsor_slug": "baptist-health-south-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05807399",
"publication_url": "https://clinicaltrials.gov/study/NCT05807399",
"title": "A Multiple-arm, Multiple-stage (MAMS), Phase 2B/C, Open-label, Randomized, Controlled Platform Trial to Evaluate Experimental Arms Including Optimised Use of Existing and Introduction of Novel Anti-tuberculosis Drugs, in Adults With Newly Diagnosed, Drug-sensitive, Smear-positive Pulmonary Tuberculosis",
"has_exemption": false,
"start_date": "2023-04-14",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Michael Hoelscher",
"sponsor_slug": "michael-hoelscher",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05707377",
"publication_url": "https://clinicaltrials.gov/study/NCT05707377",
"title": "A Phase 2/3, Multicenter, Randomized, Active-Controlled, Open-label Study to Evaluate the Efficacy and Safety of Zanubrutinib in Patients With Primary Membranous Nephropathy",
"has_exemption": false,
"start_date": "2023-04-17",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BeOne Medicines",
"sponsor_slug": "beone-medicines",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05712057",
"publication_url": "https://clinicaltrials.gov/study/NCT05712057",
"title": "Neurostimulation Enhanced Cognitive Restructuring for Transdiagnostic Emotional Dysregulation: A Component Analysis",
"has_exemption": false,
"start_date": "2023-05-15",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Duke University",
"sponsor_slug": "duke-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02615184",
"publication_url": "https://clinicaltrials.gov/study/NCT02615184",
"title": "A Phase 2, Double-Blind, 36-Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Subjects Aged 2 to 11 Years With EE",
"has_exemption": false,
"start_date": "2023-05-23",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Takeda",
"sponsor_slug": "takeda",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05564598",
"publication_url": "https://clinicaltrials.gov/study/NCT05564598",
"title": "A Phase II Open-Label Randomized Study of Anti-Viral Antibiotic Therapy With and Without Familial (Maternal) Cytomegalovirus (CMV) Cytotoxic T Lymphocytes (CTLs) in Neonates With Moderate/Severe Maternal Acquired CMV Infection",
"has_exemption": false,
"start_date": "2023-07-01",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "New York Medical College",
"sponsor_slug": "new-york-medical-college",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05901675",
"publication_url": "https://clinicaltrials.gov/study/NCT05901675",
"title": "Enhancing Mobility and Psychosocial Function in Obese Veterans Following Stroke Via Weight Loss and ExeRcise (EMPOWER)",
"has_exemption": false,
"start_date": "2023-07-07",
"completion_date": "2027-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical University of South Carolina",
"sponsor_slug": "medical-university-of-south-carolina",
"status": "ongoing",
"is_pact": false,
"days_late": null
}
]
}